𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cavernous hemangioma of the breast: Mammographic and sonographic findings and follow-up in a patient receiving hormone-replacement therapy

✍ Scribed by Benoît Mesurolle; Marvin Wexler; Fawaz Halwani; Ann Aldis; Anna Veksler; Ellen Kao


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
394 KB
Volume
31
Category
Article
ISSN
0091-2751

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We report the case of a 78‐year‐old woman who had been receiving hormone‐replacement therapy (HRT) for 6 years and had a 4‐month history of a painless nodule in the 9 o'clock position in her right breast. Mammography performed 4 years previously had shown a 4‐mm bilobed, ovoid, well‐defined nodule in that location; mammography performed 1 year previously had shown that the nodule had increased to 6 mm. We performed mammographic and sonographic examinations, which revealed a 10‐mm ovoid nodule in the same 9 o'clock position in the right breast. The imaging findings appeared to indicate benignity, but because of the increasing size of the nodule, we undertook an ultrasound‐guided large‐core needle biopsy. The histopathologic diagnosis was typical cavernous hemangioma. It was not excised, but HRT was discontinued. Follow‐up mammography and sonography 8 months later showed that the nodule had decreased to 6 mm. We believe that the HRT played a contributory role in the increasing size of this patient's cavernous hemangioma. The use of ultrasound‐guided large‐core needle biopsy is reliable enough to ascertain the benignity of such masses and can thus avoid, if it is clinically appropriate, the need for their surgical removal. © 2003 Wiley Periodicals, Inc. J Clin Ultrasound 31:430–436, 2003


📜 SIMILAR VOLUMES


A novel mutation of the GAA gene in a Fi
✍ Mari P. Korpela; Anders Paetau; Mervi I. Löfberg; Marjut H. Timonen; Antti E. La 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract Pompe disease is a rare, progressive disease leading to skeletal muscle weakness due to deficiency of the acid α‐glucosidase (GAA) enzyme. Herein we report the first diagnosed Finnish patient with a phenotype compatible with the late‐onset form of Pompe disease. Molecular genetic analys